https://www.selleckchem.com/pr....oducts/Nevirapine(Vi
After being treated with the UMC approach, the rates of well-controlled asthma ranged from 67.6% to 91.1%. During 1 year with UMC treatment, pulmonary function remained stable and only 7 subjects (6.3%) developed exacerbation. The UMC step-down treatment for well-controlled mild asthma was relatively efficient in maintaining asthma control, stabilization of pulmonary function, and reducing risk of severe exacerbation. The UMC step-down treatment for well-controlled mild asthma was relatively efficient in maintaining asthma
Like
Comment
Share
